Searched for
EIR
Dabur India shares in focus after US FDA places drugs from Silvassa plant under import alert. Here’s whyDabur India shares are set to be in focus after the US FDA issued an import alert on drugs manufactured at its Silvassa plant, citing data ...- RBI declines pleas for more time, ECL to be effective from April 2027The Reserve Bank of India will implement a new Expected Credit Loss provisioning system from April 1, 2025. Banks must adopt this proactive...
- Soon Gandhi, Vajpayee to come alive in AI avatar at PM Museum in DelhiVisitors to Delhi's Pradhanmantri Sangrahalaya will soon interact with AI avatars of Mahatma Gandhi and Atal Bihari Vajpayee. This initiati...
- Lupin receives USFDA EIR for Goa facility with VAI statusDrug maker Lupin said it has received an Establishment Inspection Report from the US Food and Drug Administration for its Goa-based manufac...
- Zydus Cadila gets EIR from USFDA for Ankleshwar facilityThe company's active pharmaceutical ingredient (API) manufacturing facility located at Ankleshwar (unit 1), Gujarat has received an Establi...
- Shilpa Medicare surges 11% on getting EIR from USFDA for Raichur unitsUSFDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection.
- Orchid Pharma gets EIR from USFDA for its Chennai facilityAs per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.
- Dr Reddy's gets EIR for Vizag plant, but inspection not closedIt, however, said the US Food and Drug Administration has not closed the inspection and the manufacturing site's status remains unchanged.
- Marksans Pharma gets EIR from USFDA for its Goa facilityAs per the USFDA, after the completion of an inspection of a facility, an EIR is issued to a company detailing inspectional findings.
- Orchid Pharma gets EIR from USFDA for its Alathur facilityOrchid Pharma today said it has received establishment inspection report (EIR) from the US health regulator for its Alathur facility in Tam...
- Glenmark's Ankleshwar plant gets EIR report from USFDA"The EIR is issued by the FDA only if it finds the facility to be deemed acceptable," the company said in a BSE filing.
- Strides Shasun R&D unit gets USFDA inspection closure reportUSFDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determine...
- Cadila Healthcare gets EIR for Ahmedabad plant from USFDA"The company's Oral Solid Dosage drug manufacturing plant located at SEZ, Ahmedabad has received an Establishment Inspection Report (EIR) f...
- Natco Pharma gets EIR from USFDA for Kothur facilityKothur facility predominantly caters to regulated international markets. EIR is given after the completion of the inspection by the USFDA.
- Cadila gets EIR from USFDA for Changodar facilityLast month, Cadila Healthcare had received Establishment Inspection Report (EIR) from the US health regulator for its manufacturing facilit...
- Strides Shasun receives EIR report from USFDAStrides's KRS Gardens facility manufactures oral dosage forms including tablets, capsules (both hard and soft gelatine).
- Orchid Pharma jumps over 13% on getting EIR report from USFDAUSFDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determine...
- Orchid Pharma gets EIR report from USFDA on inspection closureUSFDA releases a copy of the EIR to the establishment that was the subject of an FDA or FDA-contracted inspection when the agency determine...
- Orchid Pharma gets EIR report from USFDA on inspection closureOrchid Pharma has received Establishment Inspection Report (EIR) from the US health regulator on the successful inspection closure for its ...
- Sharon receives EIR report from USFDA on inspection closureSharon Bio-Medicine said it has received the establishment inspection report (EIR) from the USFDA on closure of inspection of its Dehradun ...
Load More
